BRADLY D CLARK MD NPI 1023098928

NPI Details

Bradly D Clark, MD is an anatomic pathology pathology in Memphis, TN. The provider is a pathologist deals with the causes and nature of disease and contributes to diagnosis, prognosis and treatment through knowledge gained by the laboratory application of the biologic, chemical and physical sciences. A pathologist uses information gathered from the microscopic examination of tissue specimens, cells and body fluids, and from clinical laboratory tests on body fluids and secretions for the diagnosis, exclusion and monitoring of disease. Bradly D Clark, MD NPI is 1023098928. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

3495 HACKS CROSS RD
MEMPHIS, TN
ZIP 38125-803
Phone: (901) 526-7444
Fax: (901) 271-2618

The NPI 1023098928 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Pap test, automated thin layer preparation; automated system and manual rescreening (HCPCS:88175)
• Detection test by nucleic acid for human papillomavirus (hpv), high-risk types (HCPCS:87624)
• Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision (HCPCS:G0145)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Pathology examination of tissue using a microscope, intermediate complexity (HCPCS:88305)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Measurement of rna of bacteria in vaginal fluid specimen (HCPCS:81513)
• Pap test (HCPCS:88141)
• Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique (HCPCS:87661)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique (HCPCS:87491)
• Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique (HCPCS:87591)
• Pap test, manual screening (HCPCS:88142)
• Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test (HCPCS:G0476)
• Special stained specimen slides to examine tissue, each additional procedure (HCPCS:88341)
• Bacterial colony count, urine (HCPCS:87086)
• Detection of mycoplasma genitalium by dna or rna probe (HCPCS:87563)
• Detection test for gardnerella vaginalis (bacteria), direct probe technique (HCPCS:87510)
• Detection test for candida species (yeast), direct probe technique (HCPCS:87480)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Special stained specimen slides to examine tissue, initial procedure (HCPCS:88342)
• Detection test by nucleic acid for trichomonas vaginalis (genital parasite), direct probe technique (HCPCS:87660)
• Bacterial urine culture (HCPCS:87088)
• Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution (HCPCS:87186)
• Detection test by nucleic acid for herpes simplex virus, amplified probe technique (HCPCS:87529)
• Detection test for gardnerella vaginalis (bacteria), amplified probe technique (HCPCS:87511)
• Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision (HCPCS:G0123)
• Special stained specimen slides to identify organisms including interpretation and report (HCPCS:88312)

The enumeration date for this NPI number is 1/18/2006 and was last updated on 5/12/2016.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.